Patents by Inventor Annemarie Stoudt Cohen

Annemarie Stoudt Cohen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9993425
    Abstract: What is described is a pharmaceutical formulation for intranasal delivery of insulin to a patient, comprising an aqueous mixture of human insulin, a solubilizing agent, a surface active agent, and a thickening agent, wherein said formulation provides a ultra-rapid acting profile to regular human insulin.
    Type: Grant
    Filed: December 7, 2011
    Date of Patent: June 12, 2018
    Assignee: Marina Biotech, Inc.
    Inventors: Henry R. Costantino, Annemarie Stoudt Cohen, Anthony P. Sileno
  • Publication number: 20120094903
    Abstract: What is described is a pharmaceutical formulation for intranasal delivery of insulin to a patient, comprising an aqueous mixture of human insulin, a solubilizing agent, a surface active agent, and a thickening agent, wherein said formulation provides a ultra-rapid acting profile to regular human insulin.
    Type: Application
    Filed: December 7, 2011
    Publication date: April 19, 2012
    Applicant: MARINA BIOTECH INC.
    Inventors: Henry R. Costantino, Annemarie Stoudt Cohen, Anthony P. Sileno
  • Publication number: 20100210506
    Abstract: What is described are pharmaceutical compositions, formulations, and uses thereof, for medicaments for intranasal delivery of insulin to a patient, comprising an aqueous mixture of human insulin, a solubilizing agent, and a surface active agent, wherein the human insulin may be rapid actin insulin.
    Type: Application
    Filed: October 20, 2006
    Publication date: August 19, 2010
    Applicant: MDRNA, INC.
    Inventors: Steven C. Quay, Annemarie Stoudt Cohen, Henry R. Costantino, Shu-Chih Chen Quay, Anthony P. Sileno, Mary S. Kleppe
  • Publication number: 20090325860
    Abstract: What is described is a pharmaceutical formulation for intranasal delivery of insulin to a patient, comprising an aqueous mixture of human insulin, a solubilizing agent, a surface active agent, and a thickening agent, wherein said formulation provides a ultra-rapid acting profile to regular human insulin.
    Type: Application
    Filed: April 19, 2007
    Publication date: December 31, 2009
    Applicant: NASTECH PHARMACEUTICAL COMPANY INC.
    Inventors: Henry R. Costantino, Annemarie Stoudt Cohen, Anthony P. Sileno